$0.6999
0.0314.63%
Last update: Nov 6, 9:29 AM
Annovis Bio Inc
ANVSNYSE
The average analyst price target for Annovis Bio is $27.88, 3883.4% above the current price. Of 8 analysts, 6 rate it Buy and 2 Hold. Targets range from $7 to $67. The latest change came on Aug 28, 2026, when Roth Capital lowered its price target on Annovis Bio from $8 to $7 and kept a Buy rating.
Price Target Range — 9 Quarters
Analyst Consensus — 8 Analysts
Rating Trend — Last 9 Months
